Minutes from April 10th
Health IT: The hidden pillar of health care reform
Date:
10th April, 2013
Speaker:
Sachin Jain, MD, MBA
Chief Medical Information and Innovation Officer
Merck Pharmaceuticals
Members Present:
Barbara Gilchrest
Joseph Majzoub
Mark Poznansky
Michael Rosenblatt
Mark Klempner
Aram Chobanian
Cocktails:
Conversation ranged from members’ recent personal experiences of the results of health care reform to new projects between the pharmaceutical industry and academia. Also mentioned was the continuing late arrival of spring to Boston.
Seminar:
Sachin Jain received a glowing introduction by Mike Rosenblatt. Including his so-called three H attribute – Harvard College, Harvard Medical School and Harvard Business School as well as significant contributions to White House policy documents in the area of Health IT. Mike also described how Sachin was selected to develop a new function around health IT at Merck. Sachin then lucidly went on to explain the essentials of healthcare reform and the pivotal or pillar like role that health IT will come to play in this process. He emphasized that this component is now part of Federal Policy around healthcare and ultimately would be assessed through the monitoring of meaningful use of health records. The advancement of health care and the electronic record were designed to address issues of quality of care, measurement of outcomes, auditing and research. Sachin was also pragmatic in his approach, by clearly describing problems related to technology adoption by Doctors/ Medical Offices, the variety of different systems out there and the need to update current operational systems. The overall aim throughout is to be more cost effective in the delivery of health care and with better outcomes. All agreed that the electronic medical record is to medicine what the car was to independent transportation. All in all, Sachin gave a very clear presentation that would support the continued adoption of this important technology into medicine across the USA.
Post Seminar Discussion:
Sachin’s interesting and provocative talk resulted in many questions related to both the up- and downsides of this new technology in medical practice. Questions of information security were raised as well as problems of the accuracy of data entry into the system based on sequential cutting and pasting of documents. An interesting discussion was initiated when the value of Health IT to Merck was raised. It is clear that the pharmaceutical industry would like to learn how their drugs are used on and off label in medical care settings beyond clinical trials. Health IT and the EMR may provide some basis to measure new aspects of post-marketing drug use, complications etc. Barbara issued the vote of thanks to Mike and Sachin for a very stimulating and informative talk, and at 8.30pm the participants left to the rain-swept streets of Boston – with yet again no real evidence for spring.